Medicare expands coverage to genetic counselors, capping patient costs at 20%.

What it does

This bill expands Medicare coverage to include genetic counseling services furnished by licensed or certified genetic counselors starting January 1, 2027. Medicare will pay 80% of the lesser of actual charges or 85% of the physician fee-schedule equivalent, and genetic counselors will be subject to balance-billing restrictions. The bill does not prevent physicians or other providers from continuing to bill for genetic counseling services they already cover.

Why we flagged it

The bill's operative mechanism is straightforward: it adds a new category of covered services to Medicare Part B and establishes payment and balance-billing rules for a specific provider type. This is routine healthcare coverage legislation, not a tax provision, appropriation, or regulatory carve-out.

What the text implies

• The bill permits interim final rulemaking by HHS, allowing implementation without full notice-and-comment, which may accelerate coverage but reduces public input on payment rates and provider qualification standards.
• The 85% physician fee-schedule cap may create payment pressure on genetic counselors relative to physicians, potentially affecting workforce supply and service availability in lower-reimbursement regions.
• The bill explicitly preserves physicians' and other providers' existing ability to bill for genetic counseling, creating potential for dual billing and market segmentation if payment rates diverge.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Medicare beneficiaries gain access to a new covered service with predictable cost-sharing (20% coinsurance) and balance-billing protections, expanding preventive and diagnostic care options. The payment cap (85% of physician fee-schedule) and coinsurance structure protect the Medicare trust fund while ensuring affordability for patients.

Who stands to gain

• genetic counselors and genetic counseling practices
• healthcare providers offering genetic counseling services
• patients/Medicare beneficiaries (reduced out-of-pocket costs)

Named in the bill

Medicare (Centers for Medicare & Medicaid Services), Social Security Act Section 1861, 1833, 1842, 1862, American Board of Genetic Counseling (ABGC), genetic counselors, physicians, state licensing boards

Where it stands

4 cosponsors: 3 Democrats, 1 Republicans.

• Jan 8, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Jan 8, 2026 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance. (text: CR S116-117)”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

9 lobbying clients named this bill on 9 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $747,000 in lobbying spend. A filing names 12 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 89% of bills with at least one filing.

John Barrasso, the sponsor, reported $408,500 in PAC receipts in the 2026 cycle.

• American Kidney Fund — $240,000 on 1 filing
• The Susan G. Komen Breast Cancer Foundation, Inc. Dba Susan G. Komen — $130,000 on 1 filing
• Stealth Biotherapeutics Inc. — $120,000 on 1 filing
• Parkinson's Foundation — $60,000 on 1 filing
• The National Society of Genetic Counselors — $60,000 on 1 filing

Lobbying Disclosure Act filings through Jul 21, 2026. A filing shows who paid to lobby on a bill it names, not what changed.